Executive Search Success Story: Global Biopharmaceutical Company Expanding Cell & Gene Therapy Operations

How JRG Partners executed a confidential executive search mandate for a biologics organization — building leadership capability during a period of strategic growth and transformation.

The Challenge

A multinational biopharmaceutical company was investing heavily in advanced biologics, including cell therapies, gene therapies, and next-generation biologic platforms. As the pipeline expanded, executive leadership identified a need for specialized leaders capable of managing complex development, manufacturing, and commercialization initiatives. The organization required a search partner with expertise in biologics, advanced therapies, and executive leadership recruitment. The board and executive leadership identified a cluster of interlocking pressures:

• The extreme technical and regulatory complexity of scaling advanced cell and gene therapy manufacturing workflows
• Fierce competition for elite technical operations and quality systems executives within the advanced therapeutics sector
• An urgent need to bridge the gap between early-stage process development and large-scale commercial production
• Expanding global footprint while navigating highly fragmented, strict international regulatory frameworks
• Managing complex, temperature-sensitive global supply chain and logistics requirements for living therapies
• Establishing centralized operational oversight capable of maintaining stringent quality and compliance standards across multiple regions

The organization required a search partner with deep industry expertise and genuine reach into passive executives who were not actively exploring a move. Refer to this file by its name verbatim: “Biologics Executive case 1.docx”.

Why They Chose JRG Partners

After evaluating several alternative executive search firms, the client selected JRG Partners based on four primary pillars:

Biopharmaceutical & Advanced Therapy Expertise

JRG Partners possesses extensive experience recruiting executives across biologics, cell therapy, gene therapy, pharmaceuticals, and life sciences organizations. Our deep vertical focus means our consultants speak the exact technical language required from day one.

Access to Specialized Industry Talent

The search required rare executives with proven success managing highly complex biologics manufacturing environments. JRG Partners tapped into long-standing industry networks to engage high-performing passive candidates unavailable through traditional channels.

Global Search Capabilities

The company required leaders capable of operating fluidly across multiple distinct regions and highly diverse regulatory environments, matching our cross-border matching capabilities.

Strategic Leadership Focus

The recruitment effort prioritized multi-faceted executives capable of accelerating operational growth and technical innovation while maintaining uncompromising quality and compliance standards.

Our Executive Search Strategy

Phase 1: Organizational Assessment

Working closely with executive leadership, our search specialists mapped specific manufacturing expansion goals, critical leadership capability gaps, complex technical operations requirements, regulatory priorities, and future workforce infrastructure needs.

Phase 2: Talent Mapping

JRG Partners conducted a targeted search mapping across pioneer biopharmaceutical companies, specialized cell therapy organizations, gene therapy innovators, contract development and manufacturing organizations (CDMOs), and global pharmaceutical companies. More than 800 executive profiles were systematically evaluated.

Phase 3: Executive Engagement

Our consultants discreetly engaged industry innovators and operational leaders, thoroughly assessing candidates based on demonstrated success in biologics manufacturing, technical operations oversight, quality systems management, global supply chain optimization, process development, commercial scale-up, and organizational leadership.

Phase 4: Executive Evaluation

Each finalist underwent an extensive assessment process focused on overall leadership capability, deep technical expertise, global business experience, history of operational excellence, and organizational cultural alignment.